Minority MOMP: An Oncogenic Mechanism or an Opportunity to Kill the Cancer Cell?

In this presentation, Dr. Robert Taylor Ripley, M.D. discusses his work in thoracic cancer research relating to minority mitochondrial outer membrane permeabilization (MOMP), including methods to predict which anti-apoptic can be utilized as a therapeutic target.

Target Audience

This CME/CE activity is designed to meet the educational needs of physicians, residents, fellows, and community providers.

Faculty and trainees within the Department of Medicine who are involved in the care of patients need to be regularly updated with the recent advances and guidelines in the fields of internal medicine and quality improvement to increase clinical knowledge, and to implement the advances and guidelines in clinical practice to enhance the quality of patient care and outcomes.

Learning Objectives

At the conclusion of the session, the participants should be able to:

  • Evaluate how environmental exposures are responsible for thoracic cancers.

  • Discuss why survival is poor once these cancers develop.

  • Explain how resistance to treatment occurs in nearly all patients and is particularly difficult to treat.

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Course opens: 
02/01/2020
Course expires: 
02/28/2022
Rating: 
0

John Goss, M.D., Planning Committee Member

Professor and Chief

Department of Surgery, Division of Abdominal Transplantation

Baylor College of Medicine

Houston, Texas

Disclosure: Nothing to disclose.

 

Scott LeMaire, M.D., Planning Committee Member

Professor

Department of Surgery, Section of Cardiothoracic Surgery

Baylor College of Medicine

Houston, Texas

Disclosure: Research support: Terumo Aortic, WL Gore and Associates, CytoSorbants; Intellectual property: Blackwell Publishing, Wiley Publishing; Advisory committee membership: Biom'up; Consultancy: Terumo Aortic.

 

Todd Rosengart, M.D., Planning Committee Member

Professor and Chair

Department of Surgery

Baylor College of Medicine

Houston, Texas

Disclosure: Nothing to disclose.

 

Shawn Stafford, M.D., Contributor

Assistant Professor

Department of Surgery

Baylor College of Medicine

Houston, Texas

Disclosure: Nothing to disclose

 

James Suliburk, M.D., Planning Committee Member

Associate Professor and Chief

Department of Surgery, Section of Endocrine Surgery

Baylor College of Medicine

Houston, Texas

Disclosure: Nothing to disclose.

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baylor College of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please login or register to take this course.